DCGONasdaqServices-Health ServicesFiscal year ends December 31
DocGo Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$0.25−0.02 (-6.11%)
Close on Oct 19, 2026
- Market cap
- $25.18M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.9051 (−78.03%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
DocGo Inc. saw revenue fall 32.4% to $294.72M over the twelve months to Jun 30, 2026. Free cash flow was -$25.83M, down 132.3% from a year earlier.
Revenue
$294.72M
-32.4% vs. a year earlier
Operating income
-$183.19M
TTM Q2 2026
Free cash flow
-$25.83M
-132.3% vs. a year earlier
EPS, diluted
-$1.96
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $25.18M
- P/E ratio
- –
- Price to sales
- 0.09
- Price to book
- 0.21
- Dividend yield
- –
- Free cash flow yield
- -102.57%
Fundamentals
- Revenue
- $294.72M
- Net income
- -$192.42M
- EPS, diluted
- -$1.96
- Free cash flow
- -$25.83M
- Book value per share
- $1.20
- Diluted shares
- 99M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$294.72M-32.4% YoY
Gross profit
–
Operating income
-$183.19M
Net income
-$192.42M
EPS, diluted
-$1.96
Free cash flow
-$25.83M-132.3% YoY
Reported periodTrailing twelve months